1649 related articles for article (PubMed ID: 16038714)
21. Risk factors for venous thromboembolism in children.
Gerotziafas GT
Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
[TBL] [Abstract][Full Text] [Related]
22. [Thrombophilic disorders in venous thromboembolism. The clinical perspective].
Schmidt B; Schellong S
Med Klin (Munich); 2003 Mar; 98(3):133-9. PubMed ID: 12647087
[TBL] [Abstract][Full Text] [Related]
23. Does thrombophilia testing help in the clinical management of patients?
Middeldorp S; van Hylckama Vlieg A
Br J Haematol; 2008 Nov; 143(3):321-35. PubMed ID: 18710381
[TBL] [Abstract][Full Text] [Related]
24. Should patients with venous thromboembolism be screened for thrombophilia?
Dalen JE
Am J Med; 2008 Jun; 121(6):458-63. PubMed ID: 18501222
[TBL] [Abstract][Full Text] [Related]
25. Thrombophilia and risk of venous thrombosis in patients with cancer.
Decousus H; Moulin N; Quenet S; Bost V; Rivron-Guillot K; Laporte S; Mismetti P
Thromb Res; 2007; 120 Suppl 2():S51-61. PubMed ID: 18023713
[TBL] [Abstract][Full Text] [Related]
26. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
[TBL] [Abstract][Full Text] [Related]
27. [Phlebothrombosis and pulmonary thromboembolism in patients with thrombophilia].
Karpenko AA; Gervaziev VB; Barkagan ZS; Tsyvkina LP
Angiol Sosud Khir; 2007; 13(1):59-64. PubMed ID: 17679975
[TBL] [Abstract][Full Text] [Related]
28. Extended treatment for venous thromboembolism: how long is long enough?
Cosmi B; Palareti G
Curr Hematol Rep; 2004 Sep; 3(5):375-81. PubMed ID: 15341706
[TBL] [Abstract][Full Text] [Related]
29. [Current criteria to determine the duration of anticoagulant therapy].
Palareti G
Recenti Prog Med; 2007 Dec; 98(12):603-6. PubMed ID: 18369033
[TBL] [Abstract][Full Text] [Related]
30. Thrombophilia in children with venous thromboembolic disease.
Revel-Vilk S; Kenet G
Thromb Res; 2006; 118(1):59-65. PubMed ID: 15993476
[TBL] [Abstract][Full Text] [Related]
31. Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis.
Martinelli I; Bucciarelli P; Passamonti SM; Battaglioli T; Previtali E; Mannucci PM
Circulation; 2010 Jun; 121(25):2740-6. PubMed ID: 20547928
[TBL] [Abstract][Full Text] [Related]
32. D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis.
Cosmi B; Legnani C; Cini M; Guazzaloca G; Palareti G
Thromb Haemost; 2005 Nov; 94(5):969-74. PubMed ID: 16363238
[TBL] [Abstract][Full Text] [Related]
33. The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.
Eichinger S; Pabinger I; Stümpflen A; Hirschl M; Bialonczyk C; Schneider B; Mannhalter C; Minar E; Lechner K; Kyrle PA
Thromb Haemost; 1997 Apr; 77(4):624-8. PubMed ID: 9134632
[TBL] [Abstract][Full Text] [Related]
34. Screening for inherited thrombophilia: indications and therapeutic implications.
De Stefano V; Rossi E; Paciaroni K; Leone G
Haematologica; 2002 Oct; 87(10):1095-108. PubMed ID: 12368166
[TBL] [Abstract][Full Text] [Related]
35. The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia.
Rossi E; Za T; Ciminello A; Leone G; De Stefano V
Thromb Haemost; 2008 Jun; 99(6):1030-4. PubMed ID: 18521504
[TBL] [Abstract][Full Text] [Related]
36. The thrombophilic pattern of different clinical manifestations of venous thromboembolism: a survey of 443 cases of venous thromboembolism.
Grifoni E; Marcucci R; Ciuti G; Cenci C; Poli D; Mannini L; Liotta AA; Miniati M; Abbate R; Prisco D
Semin Thromb Hemost; 2012 Mar; 38(2):230-4. PubMed ID: 22422337
[TBL] [Abstract][Full Text] [Related]
37. Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study.
Glynn RJ; Ridker PM; Goldhaber SZ; Zee RY; Buring JE
Circulation; 2007 Sep; 116(13):1497-503. PubMed ID: 17846285
[TBL] [Abstract][Full Text] [Related]
38. Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal.
Legnani C; Mattarozzi S; Cini M; Cosmi B; Favaretto E; Palareti G
Br J Haematol; 2006 Jul; 134(2):227-32. PubMed ID: 16846482
[TBL] [Abstract][Full Text] [Related]
39. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
Agnelli G; Prandoni P; Santamaria MG; Bagatella P; Iorio A; Bazzan M; Moia M; Guazzaloca G; Bertoldi A; Tomasi C; Scannapieco G; Ageno W;
N Engl J Med; 2001 Jul; 345(3):165-9. PubMed ID: 11463010
[TBL] [Abstract][Full Text] [Related]
40. Thrombophilia and venous thromboembolism: implications for testing.
Cohn DM; Roshani S; Middeldorp S
Semin Thromb Hemost; 2007 Sep; 33(6):573-81. PubMed ID: 17768689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
